DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Taylor SI, Blau JE, Rother KI. et al
SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks.
Lancet Diabetes Endocrinol 2019;
7: 949-958
DOI: 10.1016/S2213-8587(19)30154-8.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.